Recurrent Bladder Cancer - CancerConnect
Non muscle invasive bladder cancer treatment - WCRJ
Non muscle invasive bladder cancer treatment - WCRJ
Diagnostics | Free Full-Text | Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review
Useful and potentially useful urine markers for bladder cancer. | Download Table
Gender-specific Differences in Recurrence of Non–muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis - European Urology Focus
Cancers | Free Full-Text | Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer
Recurrent ZNF83-E293V Mutation Promotes Bladder Cancer Progression through the NF-κB Pathway via Transcriptional Dysregulation of S100A8: Molecular Therapy
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective | Nature Reviews Urology
Frontiers | Urinary Markers in Bladder Cancer: An Update
Bladder Cancer Markers and Recent Innovations | IntechOpen
Life | Free Full-Text | Proteomics for Early Detection of Non-Muscle-Invasive Bladder Cancer: Clinically Useful Urine Protein Biomarkers
Unmet Clinical Needs and Future Perspectives in Non–muscle-invasive Bladder Cancer - European Urology Focus
ABYNTEK | Tumor markers for cancer research: FAQS
Tumor Markers - Priority Health
Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation | PLOS ONE
Dr. Peter Black | Urine Markers for Bladder Cancer | The Ideal Marker
Cells | Free Full-Text | Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer
Summary of urinary markers for bladder cancer | Download Table
Urinary peptide panel for prognostic assessment of bladder cancer relapse | Scientific Reports
FEP 2.04.07 Urinary Biomarkers for Cancer Screening, Diagnosis, and Surveillance
Bladder Cancer Biomarkers | Encyclopedia MDPI
Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight - ScienceDirect
Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era | Nature Reviews Urology
